38 results on '"Habert, Marie-Odile"'
Search Results
2. Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group (IWG)
3. Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints
4. Predicting factors of cognitive progression in preclinical AD: A five‐year follow‐up of the insight‐study
5. Dementia with Lewy bodies: Characteristics of the prodromal stage in a nationwide longitudinal cohort
6. Association of plasma YKL‐40 with brain amyloidosis, memory performance, and sex in subjective memory complainers
7. Reduced awareness of cognitive decline is associated with brain amyloid load in asymptomatic elderly individuals at risk for AD: A longitudinal study
8. Aging and sex impact plasma NFL and t‐Tau trajectories in individuals at risk for Alzheimer’s disease
9. Occupational burnout‐like syndrome in early‐onset Alzheimer’s disease
10. P1-243: BIOMARKER-GUIDED STRATIFICATION APPROACH OF THE CLINICAL CONTINUUM OF ALZHEIMER'S DISEASE USING UNSUPERVISED CLUSTERING METHODS
11. O1‐06‐04: ASSOCIATION BETWEEN HYPERTENSION AND ALZHEIMER'S DISEASE AND RELATED CAUSES OF DEMENTIA: A PATHWAYS ANALYSIS IN THE MEMENTO COHORT
12. P2-034: PLASMA BETA-SECRETASE 1 CONCENTRATIONS PREDICT GLOBAL AND REGIONAL BRAIN BURDEN OF AMYLOID-β IN COGNITIVELY NORMAL INDIVIDUALS AT RISK FOR AD: CROSS-SECTIONAL AND LONGITUDINAL STUDIES
13. O3-11-02: LATENT CLASS ANALYSIS IDENTIFIES FUNCTIONAL DECLINE WITH AMSTERDAM IADL IN PRE-CLINICAL ALZHEIMER'S DISEASE
14. O4-07-05: NIA-AA RESEARCH FRAMEWORK: APPLICATION TO THE FRENCH POPULATION BY INFERENCE FROM THE MEMENTO COHORT
15. O3‐06‐03: AWARENESS OF MEMORY DECLINE IN ASYMPTOMATIC AT RISK FOR ALZHEIMER'S DISEASE: THE META‐MEMORY RATIO
16. P3‐411: CLINICAL SIGNIFICANCE OF IN‐VIVO STAGING OF REGIONAL AMYLOID DEPOSITION IN SUBJECTIVE MEMORY COMPLAINERS
17. P2‐246: INCREASED LONGITUDINAL DYNAMICS OF PLASMA YKL‐40 CONCENTRATIONS IN AMYLOID‐PET POSITIVE INDIVIDUALS WITH SUBJECTIVE MEMORY COMPLAINTS
18. P1‐627: AMYLOID BURDEN IMPACTS EVERYDAY FUNCTIONING INDEPENDENT OF COGNITION AND AWARENESS IN SUBJECTIVE COGNITIVE DECLINE: FINDINGS FROM THE INSIGHT PRE‐AD COHORT
19. O3‐12‐04: THE NEURONAL COMPENSATION MODEL OF THE PRECLINICAL STAGE OF ALZHEIMER'S DISEASE: RESULTS FROM THE INSIGHT‐PRE AD STUDY
20. P4‐072: INCREASED PLASMA BACE1 CONCENTRATIONS IN WOMEN WITH SUBJECTIVE MEMORY COMPLAINTS: CORRELATION WITH PLASMA NFL
21. IN COGNITIVELY NORMAL INDIVIDUALS, THE BEST CONCORDANCE BETWEEN CSF BIOMARKERS AND PET AMYLOID IS OBSERVED WITH THE COMBINATION OF B-AMYLOID1-42 AND PHOSPHORYLATED TAU
22. [IC-P-152]: ASSOCIATION OF CORTICAL AMYLOID LOAD WITH RESTING-STATE EEG FUNCTIONAL CONNECTIVITY IN SUBJECTIVE MEMORY COMPLAINERS FROM THE INSIGHT-PRE AD STUDY
23. [P1-441]: ASSOCIATION OF CORTICAL AMYLOID LOAD WITH RESTING-STATE EEG FUNCTIONAL CONNECTIVITY IN SUBJECTIVE MEMORY COMPLAINERS FROM THE INSIGHT-PRE-AD STUDY
24. [P1-378]: ADDED VALUE OF FLORBETABEN PET IMAGING ON DIAGNOSIS AND MANAGEMENT IN COMPLEX CASES OF PATIENTS WITH MILD DEMENTIA ELIGIBLE FOR CSF ANALYSIS IN THE FRENCH CLINICAL PRACTICE SETTING
25. [P4–184]: LOW COGNITIVE AWARENESS, BUT NOT COMPLAINT, IS A GOOD MARKER OF PRECLINICAL ALZHEIMER'S DISEASE
26. [P4-302]: DOES BRAIN AMYLOID DEPOSITION IMPACT EVERYDAY FUNCTIONING IN SUBJECTS WITH COGNITIVE COMPLAINTS? RESULTS FROM THE INSIGHT COHORT
27. Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept
28. P2-151: Cerebrospinal Fluid Biomarker Profile of Amyloid, TAU, Synaptic, Microglial, and Lysosomal Pathophysiology in Cognitively Normal Preclinical Individuals Stratified by Amyloid-Pet Status
29. P3‐165: Plasma Biomarker Profile of Amyloid, TAU, and Neuronal Pathophysiology in Cognitively Normal Preclinical Individuals Stratified by Amyloid‐Pet Status
30. P1-235: The Memory Binding Test (MBT) in Subjects with Subjective Memory Decline (SMD)
31. The phenotypical core of Alzheimer's disease‐related and nonrelated variants of the corticobasal syndrome: A systematic clinical, neuropsychological, imaging, and biomarker study
32. P2-091: USEFULNESS OF THE PET-PIB IMAGING FOR THE DIAGNOSIS OF AD IN DAILY CLINICAL PRACTICE
33. P1-249: ASSOCIATION BETWEEN MULTIPLE NEUROIMAGING MARKERS AND COGNITIVE PROFILES IN THE MEMENTO COHORT
34. P2-068: Frontal presentations of Alzheimer's disease: A series of people with biological evidence by CSF biomarkers
35. P2-073: Validation of the amnestic syndrome of the hippocampal type in Alzheimer's disease using CSF biomarkers and PiB-PET
36. P1-105: Behavioral variant of Alzheimer's disease in an old woman mimicking frontotemporal dementia: Diagnosis contribution of CSF biomarkers
37. P2-029: Similar beta-amyloid burden in posterior cortical atrophy and Alzheimer's disease
38. P2-004: Brain perfusion SPECT profile in posterior cortical atrophy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.